Brought to you by 
Eli Lilly, Receptos sign GPCR alliance
03 Mar 2011
Executive Summary
Drug discovery company Receptos Inc. has signed its second Big Pharma deal so far this year, this time joining forces with Eli Lilly & Co. to find new small-molecule modulators of an undisclosed GPCR target.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Eli Lilly, Receptos sign GPCR alliance
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice